# BELRAPZO
> **NDA205580** · New Drug Application · Sponsor: EAGLE PHARMS · Approved 2018-05-15
## Drug
- **FDA Application Number:** NDA205580
- **Application type:** New Drug Application
- **Brand name:** BELRAPZO
- **Generic name:** BENDAMUSTINE HYDROCHLORIDE
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EAGLE PHARMS
- **Manufacturer:** Eagle Pharmaceuticals, Inc
- **First approval:** 2018-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205580)
---
*AI Analytics · CC0 1.0*